Home » Topics » Conferences

Conferences
RSS

Corvas presents phase I trial results of novel injectable anticoagulant at ACC meeting

March 9, 1999

Spotlight on double and triple enzyme inhibitors for treating cardiovascular disease

Feb. 24, 1999

Renal protective effects of azelnidipine involve inhibition of AGE production

Feb. 22, 1999

Antihypertensive effects of bradykinin agonist FR-190997 evaluated in animals

Feb. 22, 1999

FR-167653 compared to dexamethasone in acute lung inflammation

Feb. 18, 1999

Antiarthritic effects, mechanism and GI safety of S-2474 evaluated in rat model

Feb. 17, 1999

S-5920 superior to methylprednisolone in protecting against ARDS

Feb. 17, 1999

Mechanism of action of T-614 in RA examined in vitro

Feb. 15, 1999

Focal angiogenic gene therapy as a novel treatment for myocardial ischemia

Feb. 15, 1999

Pediatric study supports use of vCP205 in infants born to HIV-positive mothers

Feb. 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...